Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

A 76-year-old woman with advanced pancreatic cancer developed recurrent cholecystitis after covered self-expandable metal stent (CSEMS) placement. The cholecystitis was refractory to repeated percutaneous transhepatic gallbladder drainage (PTGBD). Cholecystography showed a patent cystic duct with right and cranial side bifurcation, which is indicative of an increased likelihood of success of endoscopic transpapillary gallbladder drainage (ETGBD). We were able to manage the cholecystitis by ETGBD without further recurrence. ETGBD is considered an effective internal drainage method for the management of acute cholecystitis after CSEMS placement, and its indication may be decided on the basis of the findings of cholecystography through the PTGBD route.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908391PMC
http://dx.doi.org/10.2169/internalmedicine.9706-22DOI Listing

Publication Analysis

Top Keywords

gallbladder drainage
12
endoscopic transpapillary
8
transpapillary gallbladder
8
recurrent cholecystitis
8
cholecystitis covered
8
covered self-expandable
8
self-expandable metal
8
metal stent
8
csems placement
8
cholecystitis
5

Similar Publications

Introduction: Laparoscopic cholecystectomy (LC) is the gold standard for gallbladder pathologies, but carries risks of bile duct injury (BDI) and vascular complications, such as hepatic artery pseudoaneurysm (HAP). While BDI occurs in 0.3-0.

View Article and Find Full Text PDF

The therapeutic value of "Bile Transfer" for complications of acute pancreatitis: A retrospective clinical study.

J Adv Res

August 2025

Department of Oncology and Laparoscopy Surgery, The First Affiliated Hospital of Harbin Medical University, 150000 Harbin, Heilongjiang Province, China; Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, 150000 Harbin, Heilongj

Introduction: Acute pancreatitis (AP) is one of the most common gastrointestinal diseases, imposing a significant burden on patients, with its incidence steadily increasing worldwide. Despite a drop in fatality rates, AP-related complications remain high, impacting prognosis.

Objectives: This retrospective clinical study introduces the concept of "bile transfer" (BT) and explores its potential in reducing AP-related complications.

View Article and Find Full Text PDF

: The TOPAZ-1 phase III trial reported a survival benefit of using durvalumab, an anti-programmed death ligand 1 (anti-PD-L1) antibody, in combination with gemcitabine and cisplatin (GCD) treatment in patients with advanced biliary tract cancer. This retrospective study investigated the efficacy and safety of GCD treatment for advanced biliary tract cancer in real-world conditions. : The study subjects were 52 patients with biliary tract cancer who received GCD therapy between January 2023 and May 2024.

View Article and Find Full Text PDF